Michigan Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center

• Category: Corporations - Public - Licenses
• State: Multi-State
• Control #: US-EG-9161
• Format: Word; Rich Text

Description

Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages Michigan Collateral License Agreement The Michigan Collateral License Agreement is a legal agreement between Gentling, Inc. and The University of North Texas Health Science Center, outlining the terms and conditions regarding the licensing of collateral materials related to their collaborative work or research. This agreement aims to protect the intellectual property rights, confidentiality, and proper usage of collateral between both parties. Key terms within the Michigan Collateral License Agreement include: 1. Intellectual Property Rights: The agreement specifies that all collateral materials, including patents, copyrights, trademarks, or trade secrets, created or developed during the collaboration, shall be owned by the appropriate party as outlined in the agreement. This provision ensures that each party retains its respective rights to the intellectual property produced during the collaboration. 2. License Grant: The agreement grants Gentling, Inc. a non-exclusive, non-transferable license to use, reproduce, distribute, or display any collateral materials provided by The University of North Texas Health Science Center solely for the purposes specified within the agreement. This facilitates the proper utilization of collateral materials by Gentling, Inc. while respecting the rights of the university. 3. Confidentiality: The agreement acknowledges the confidential nature of certain collateral materials and emphasizes the need for both parties to maintain strict confidentiality standards. It outlines obligations for handling confidential information and restricts disclosure to third parties without prior written consent from the disclosing party. 4. Term and Termination: The agreement specifies the duration of the license grant and the conditions under which either party can terminate the agreement. It may include provisions for termination due to breach of contract, expiration of the collaboration, or mutual agreement between parties. 5. Types of Michigan Collateral License Agreements: While the exact types of Michigan Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center may vary based on specific projects or collaborations, there might be agreements related to research collaborations, technology transfer, joint ventures, or collaborative patent licensing. Each type of agreement would address the unique requirements and objectives of the collaboration. In conclusion, the Michigan Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center serves as a crucial legal document to govern the licensing and usage of collateral materials resulting from their collaborative work. It ensures the protection of intellectual property rights, promotes confidentiality, and establishes guidelines regarding the proper utilization of collateral materials.

Michigan Collateral License Agreement The Michigan Collateral License Agreement is a legal agreement between Gentling, Inc. and The University of North Texas Health Science Center, outlining the terms and conditions regarding the licensing of collateral materials related to their collaborative work or research. This agreement aims to protect the intellectual property rights, confidentiality, and proper usage of collateral between both parties. Key terms within the Michigan Collateral License Agreement include: 1. Intellectual Property Rights: The agreement specifies that all collateral materials, including patents, copyrights, trademarks, or trade secrets, created or developed during the collaboration, shall be owned by the appropriate party as outlined in the agreement. This provision ensures that each party retains its respective rights to the intellectual property produced during the collaboration. 2. License Grant: The agreement grants Gentling, Inc. a non-exclusive, non-transferable license to use, reproduce, distribute, or display any collateral materials provided by The University of North Texas Health Science Center solely for the purposes specified within the agreement. This facilitates the proper utilization of collateral materials by Gentling, Inc. while respecting the rights of the university. 3. Confidentiality: The agreement acknowledges the confidential nature of certain collateral materials and emphasizes the need for both parties to maintain strict confidentiality standards. It outlines obligations for handling confidential information and restricts disclosure to third parties without prior written consent from the disclosing party. 4. Term and Termination: The agreement specifies the duration of the license grant and the conditions under which either party can terminate the agreement. It may include provisions for termination due to breach of contract, expiration of the collaboration, or mutual agreement between parties. 5. Types of Michigan Collateral License Agreements: While the exact types of Michigan Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center may vary based on specific projects or collaborations, there might be agreements related to research collaborations, technology transfer, joint ventures, or collaborative patent licensing. Each type of agreement would address the unique requirements and objectives of the collaboration. In conclusion, the Michigan Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center serves as a crucial legal document to govern the licensing and usage of collateral materials resulting from their collaborative work. It ensures the protection of intellectual property rights, promotes confidentiality, and establishes guidelines regarding the proper utilization of collateral materials.